Cardiovascular Research Institute

Medicine & Life Sciences

1. Atherosclerosis 100%
2. Atherosclerotic Plaques 78%
3. Noonan Syndrome 57%
4. Magnetic Resonance Imaging 56%
5. Positron-Emission Tomography 45%
6. Genes 41%
7. Inflammation 40%
8. Cardiovascular Diseases 40%
9. Cardiac Myocytes 40%
10. Heart Diseases 38%
11. Nanoparticles 38%
12. Magnetic Resonance Spectroscopy 37%
13. Coronary Artery Disease 37%
14. Mutation 36%
15. Heart 35%
16. Contrast Media 35%
17. Molecular Imaging 30%
18. Macrophages 29%
19. Blood Vessels 27%
20. Therapeutics 27%
21. Myocardial Infarction 27%
22. Fluorodeoxyglucose F18 27%
23. Lipids 26%
24. Phenotype 23%
25. Percutaneous Coronary Intervention 21%
26. Coronary Vessels 20%
27. Congenital Heart Defects 19%
28. Extracellular Vesicles 19%
29. Heart Failure 19%
30. LEOPARD Syndrome 18%
31. Genome 18%
32. Coronavirus 18%
33. Induced Pluripotent Stem Cells 18%
34. Rabbits 17%
35. Aorta 17%
36. Precision Medicine 17%
37. Cathepsin K 17%
38. HDL Lipoproteins 16%
39. Positron Emission Tomography Computed Tomography 16%
40. Pycnodysostosis 16%
41. Pulmonary Hypertension 15%
42. Pluripotent Stem Cells 15%
43. Carotid Arteries 15%
44. Marfan Syndrome 14%
45. Arteritis 14%
46. Tomography 14%
47. Proteins 14%
48. Thrombosis 13%
49. Whole Genome Sequencing 13%
50. Stem Cells 13%
51. Regeneration 13%
52. Technology 13%
53. Mortality 13%
54. Hypertrophic Cardiomyopathy 13%
55. Exosomes 12%
56. Fibromuscular Dysplasia 12%
57. In Vitro Techniques 12%
58. Cardiomyopathies 12%
59. Pulmonary Arterial Hypertension 12%
60. Hydroxymethylglutaryl-CoA Reductase Inhibitors 12%
61. Calcium 12%
62. Arteries 11%
63. Thoracic Aorta 11%
64. Stents 11%
65. Neoplasms 11%
66. Swine 11%
67. ferric oxide 11%
68. Lung 11%
69. Genetic Therapy 11%
70. Smooth Muscle Myocytes 10%
71. Rupture 10%
72. Myocardium 10%
73. Cell Proliferation 10%
74. Germ-Line Mutation 10%
75. Micelles 10%
76. Abdominal Aorta 10%
77. Biomarkers 10%
78. Pediatrics 10%
79. SARS Virus 9%
80. Apolipoproteins E 9%
81. Cardiofaciocutaneous syndrome 9%
82. Gadolinium 9%
83. Genomics 9%
84. Child 9%
85. Thorax 9%
86. Vascular Diseases 9%
87. Char syndrome 9%
88. Gene Expression 9%
89. Nanomedicine 9%
90. Population 9%
91. Vascular Remodeling 9%
92. Mesenchymal Stem Cells 9%
93. Messenger RNA 9%
94. Abdominal Aortic Aneurysm 9%
95. Adeno-associated virus-1 9%
96. Animal Models 9%
97. Safety 8%
98. Cardiology 8%
99. Missense Mutation 8%
100. Pharmaceutical Preparations 8%